Chemokines Do More Than Direct Traffic

Research from the University of Fribourg reveals that CCL21 does more than direct immune cell traffic, it actively terminates CD8 T cell activation by breaking apart the physical contact between T cells and dendritic cells (DCs) at precisely the right moment.
Read More

New Study Confirms Safety of CCL20LD

Research from co-founder Dr. Mike Dwinell's lab at the Medical College of Wisconsin advances XLock Biosciences' lead therapeutic candidate.
Read More
More results: 1 2 3 Next Page
TOP Logo